| Mr Gary E Johnson, MSW | |
|
1515 E Silver Springs Blvd, Suite 112, Ocala, FL 34470-6831 | |
| (352) 732-3333 | |
| (352) 732-2469 |
| Full Name | Mr Gary E Johnson |
|---|---|
| Gender | Male |
| Speciality | Clinical Social Worker |
| Experience | 43 Years |
| Location | 1515 E Silver Springs Blvd, Ocala, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033257076 | NPI | - | NPPES |
| Z3110 | Other | FL | BCBS OF FLORIDA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | SW0002223 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aet Of Central Florida Of Schaeffer And Henderson, P.a. | 9032379466 | 3 |
News Archive
Scientists from A*STAR's Genome Institute of Singapore and the Cancer Science Institute of Singapore at the National University of Singapore came together to understand how EZH2, a cancer-promoting gene which is known to be involved in many types of cancers, is activated in breast cancer and lymphomas.
"Real-world" use of a novel drug-eluting stent coated with a biodegradable polymer is associated with good clinical outcomes, according to one-year data from a large international registry.
Cardiac Science announced its donation of five Powerheart G5 automated external defibrillators to furnish Cristo Rey Jesuit Atlanta High School's new facilities at 222 Piedmont Avenue.
Onyx Pharmaceuticals, Inc. today announced the presentation of several studies evaluating carfilzomib, a selective, next-generation proteasome inhibitor, at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8, 2010 in Chicago, IL.
› Verified 6 days ago
| Entity Name | Aet Of Central Florida Of Schaeffer & Henderson, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366454308 PECOS PAC ID: 9032379466 Enrollment ID: O20120322000234 |
News Archive
Scientists from A*STAR's Genome Institute of Singapore and the Cancer Science Institute of Singapore at the National University of Singapore came together to understand how EZH2, a cancer-promoting gene which is known to be involved in many types of cancers, is activated in breast cancer and lymphomas.
"Real-world" use of a novel drug-eluting stent coated with a biodegradable polymer is associated with good clinical outcomes, according to one-year data from a large international registry.
Cardiac Science announced its donation of five Powerheart G5 automated external defibrillators to furnish Cristo Rey Jesuit Atlanta High School's new facilities at 222 Piedmont Avenue.
Onyx Pharmaceuticals, Inc. today announced the presentation of several studies evaluating carfilzomib, a selective, next-generation proteasome inhibitor, at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8, 2010 in Chicago, IL.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Gary E Johnson, MSW Po Box 2854, Ocala, FL 34478-2854 Ph: (352) 732-3333 | Mr Gary E Johnson, MSW 1515 E Silver Springs Blvd, Suite 112, Ocala, FL 34470-6831 Ph: (352) 732-3333 |
News Archive
Scientists from A*STAR's Genome Institute of Singapore and the Cancer Science Institute of Singapore at the National University of Singapore came together to understand how EZH2, a cancer-promoting gene which is known to be involved in many types of cancers, is activated in breast cancer and lymphomas.
"Real-world" use of a novel drug-eluting stent coated with a biodegradable polymer is associated with good clinical outcomes, according to one-year data from a large international registry.
Cardiac Science announced its donation of five Powerheart G5 automated external defibrillators to furnish Cristo Rey Jesuit Atlanta High School's new facilities at 222 Piedmont Avenue.
Onyx Pharmaceuticals, Inc. today announced the presentation of several studies evaluating carfilzomib, a selective, next-generation proteasome inhibitor, at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8, 2010 in Chicago, IL.
› Verified 6 days ago
Ryan Laverdiere, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3032 Ne 37th Pl, Ocala, FL 34479 Phone: 719-588-8154 | |
Anamary Cruz, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2805 Ne 45th Ave, Ocala, FL 34470 Phone: 352-421-8991 | |
Kristen Ann Sims, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3700 Ne 22nd Ct, Ocala, FL 34479 Phone: 386-334-3503 | |
Connor Dillon Carey, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 5664 Sw 60th Ave, Ocala, FL 34474 Phone: 352-291-5555 Fax: 352-291-5582 | |
Monika Tchernavia Morrissette, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2 Hemlock Trace, Ocala, FL 34472 Phone: 909-518-3925 | |
Kathryn Burlile, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11179 Sw 54th Cir, Ocala, FL 34476 Phone: 352-275-9671 |